Baltimore, MD, United States of America

Charles Williams Flexner

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Johns Hopkins University, University of Liverpool. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Charles Williams Flexner

Introduction

Charles Williams Flexner is an accomplished inventor based in Baltimore, MD (US). He holds two patents that showcase his contributions to the field of antiviral therapeutics. His work focuses on developing innovative solutions for chronic viral infections, demonstrating his commitment to advancing medical science.

Latest Patents

Flexner's latest patents include "Self-assembling antiviral prodrugs" and "Prodrug compositions." The first patent discloses therapeutic self-assembling molecules that include a peptide sequence conjugated to antiviral therapeutics. These molecules can self-assemble into supramolecular structures in aqueous solutions, allowing for subcutaneous or intramuscular injection for long-acting treatment of chronic viral infections. The second patent provides a composition comprising nanoparticles of prodrugs of certain pharmaceutically active agents, which are dispersed within a carrier material. This invention also outlines processes for creating these compositions.

Career Highlights

Throughout his career, Flexner has made significant contributions to the field of pharmaceutical sciences. His work has been recognized for its potential impact on the treatment of viral infections, showcasing his innovative approach to drug development.

Collaborations

Flexner has collaborated with notable individuals such as Honggang Cui and Maya Monroe. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Charles Williams Flexner's innovative work in antiviral therapeutics highlights his dedication to improving healthcare solutions. His patents reflect a significant advancement in the treatment of chronic viral infections, underscoring his role as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…